Bupivacaine
Long-acting local anesthetic for regional anesthesia and pain management.
Product Overview
Bupivacaine hydrochloride is a long-acting amide local anesthetic used for infiltration, peripheral nerve block, and epidural anesthesia. Available with and without epinephrine for varying duration requirements.
| Product | Concentration | Fill Volume | Epinephrine | Container | BUD |
|---|---|---|---|---|---|
| Bupivacaine HCl 0.25% | 2.5 mg/mL | 10 mL | No | SDV | 24 months |
| Bupivacaine HCl 0.50% | 5 mg/mL | 10 mL | No | SDV | 24 months |
| Bupivacaine 0.25% with Epinephrine | 2.5 mg/mL | 10 mL | 1:200,000 | SDV | 12 months |
| Bupivacaine 0.50% with Epinephrine | 5 mg/mL | 10 mL | 1:200,000 | SDV | 12 months |
Related Articles
April 15, 2023
Medivant Healthcare Announces Launch of Bupivacaine with Epinephrine 10 mL Vial
Medivant Healthcare announces the launch of Bupivacaine with Epinephrine 10 mL vial, a preservative-free formulation designed for reliable and precise anesthesia applications.
Read More
April 5, 2021
Medivant Healthcare Announces Release of Bupivacaine 0.5%
Medivant Healthcare announces the release of Bupivacaine 0.5%, now available to hospitals nationwide.
Read More
January 10, 2026
Medivant Healthcare Partners with Angels for Change to Address Drug Shortages
Medivant Healthcare announces its partnership with Angels for Change and the upcoming launch of Lorazepam injectable vials to help address critical drug shortages.
Read MoreRequest Product Information
Contact our team for specifications, pricing, and availability.